Our patented technology allows the production of activated sugars at a fraction of the existing suppliers' prices. By using highly efficient multi-enzyme cascades, we can synthesize activated sugars from inexpensive substrates. Our goal is to make them available for diverse applications in food and pharma, including novel complex human milk oligosaccharides and modifying antibodies' glycosylation efficiently. All enzymes are also produced in-house cheaply simultaneously in one strain, making it favorable from a regulatory perspective. Our synthesis processes are scalable and protected by our IP portfolio.